Can Fite Biopharma Ltd (NYSE American:CANF)
| 3.95 Delayed Data As of Feb 03 |  0.00 / 0.00%Today’s Change | 3.78 Today|||52-Week Range 12.90 | -35.56% Year-to-Date |
Latest CANF News | Press Releases
No recent news for Can Fite Biopharma Ltd.
Today’s Trading
| Previous close | 3.95 |
| Today’s open | 3.94 |
| Day’s range | 3.91 - 3.96 |
| Volume | 30,082 |
| Average volume (3 months) | 35,937 |
| Market cap | $13.2M |
Data as of 3:51pm ET, 02/03/2023
Growth & Valuation
| Earnings growth (last year) | +35.00% |
| Earnings growth (this year) | -1,064.10% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | +11.80% |
| P/E ratio | NM |
| Price/Sales | 27.88 |
| Price/Book | 0.74 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NDRAENDRA Life Sciences ... | +0.05 | +1.19% |
| HMTXFHemostemix Inc | +0.01 | +6.33% |
| ONVOOrganovo Holdings In... | 0.00 | 0.00% |
| IMNNImunon Inc | 0.00 | 0.00% |
Data as of 4:00pm ET, 02/03/2023
Financials
| Next reporting date | March 23, 2023 |
| EPS forecast (this quarter) | -$0.91 |
| Annual revenue (last year) | $853.0K |
| Annual profit (last year) | -$12.6M |
| Net profit margin | -1,478.90% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Petach Tikva, Hamerkaz |
Forecasts
